Shire sells cancer drugs to Servier as Takeda circles

Sharing is Caring

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire’s portfolio – despite a dismal share price performance in the past two years.

Shire sells cancer drugs to Servier as Takeda circles

Tags : selling, Sellingpharmaceutical, target, Potential, 24 billion, french, Takeover, Takeda, Drugmaker, japan, Shire, Servier, Oncology, Pharmaceutical

Related Videos :

You may also like...

Leave a Reply